ITEM 1.01 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On October 30, 2020, the Board of Directors (the "Board") of Marizyme, Inc. ("Marizyme"), with an effective date of November 1, 2020, the Board appointed Dr. Neil J. Campbell as chief executive officer, president and director of the Marizyme. Dr. Campbell has an extensive background in life sciences and management. Dr. Campbell's compensation will be $375,000 annually and various stock incentives.

James Sapirstein, the interim chief executive officer, will depart his interim role on November 1, 2020 and resume his role as chairman.

Dr. Satish Chandran will relinquish his title as president and chief operating officer and will assume his new role as co-founder and chief technology officer.





Dr. Neil J. Campbell

Dr. Campbell is President & CEO of Marizyme, Inc. and a member of the Board of Directors. Dr Campbell currently serves as Chairman of Mosaigen, a commercial development company and RespaRx, a medical device company. Dr. Campbell has over 30 years of successful experience with public and private companies in the life sciences, medical, healthtech, nanotechnology, artificial intelligence, and high-performance computing technologies.

Previously, Dr. Campbell was Chairman, CEO, and founder of Celios, a respiratory device company that was acquired by a private investment group and is now selling his proprietary technologies on national television. Prior to founding Celios, Dr. Campbell was co-founder, President and CEO of Helomics, a personalized healthcare company focused on next-generation therapeutics and diagnostics.

Dr. Campbell has prior institutional investment experience as a partner in venture capital, and operating partner and industry advisor in private equity. Dr. Campbell has also held senior executive positions at SuperNova Diagnostics, EntreMed Pharmaceuticals, Life Technologies, IGEN International (now Roche), Celera Genomics, and Abbott Laboratories. Dr. Campbell has also held academic positions at Johns Hopkins University and Medical Institutes, Hong Kong University of Science and Tech (HKUST), University of Liverpool (UK), University of Baltimore and Duquesne University. Dr. Campbell is a veteran of the U.S. Air Force.

Dr. Campbell received his B.S. from Norwich University, M.A. and M.B.A. from Webster University and Doctorate from the University of Liverpool in the United Kingdom.

ITEM 9.01 Financial Statement and Exhibits





(d) Exhibits

The following exhibits are filed herewith:





Exhibit No.   Description of Exhibit
  99.1        Employment Agreement dated November 1, 2020.
  99.2        Press Release dated November 5, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses